Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study (Q33671152)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study |
scientific article |
Statements
1 reference
Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study (English)
1 reference
Jean-Michel Molina
1 reference
Rebekah L Puls
1 reference
Preeyaporn Srasuebkul
1 reference
Kathy Petoumenos
1 reference
Christoph Boesecke
1 reference
Chris Duncombe
1 reference
Waldo H Belloso
1 reference
Lin Li
1 reference
Anchalee Avihingsanon
1 reference
Brian Gazzard
1 reference
David A Cooper
1 reference
Altair Study Group
1 reference
1 October 2010
1 reference
1 reference
Identifiers
1 reference